2011-07-02

The SUMC Affiliated Cancer Hospital is China’s proud first adopter of the state-of-the-art TrueBeam system – an innovative fully-integrated system for fast and precise image-guided radiotherapy that could radically advance the treatment of lung, breast, prostate, head and neck, and other types of cancer.

A dedication ceremony has been held recently at the affiliated hospital to celebrate the completion of installation of this important gift to SUMC donated by the Li Ka Shing Foundation.

Speaking at the dedication ceremony, Director of the SUMC Affiliated Cancer Hospital, Professor Zhang Guojun, said TrueBeam’s small, high-intensity fields of radiation would be a great addition to the hospital’s full line of cancer treatment technologies. “This new technology, combined with our physicians’ expertise and commitment in patient care, will offer a new chapter of possibilities for our cancer treatments in our long and hard battle against cancer,” Professor Zhang said.

Since its founding in 1994, the cancer hospital has been committed to providing cancer patients with the best multimodality treatment including chemotherapy, surgery and radiotherapy. The hospital is equipped with eight operating rooms and 11 wards with 416 beds for patients, served by 120 physicians and 74 medical technicians of different expertise. With its modern diagnostics, the hospital each year treats over 75,000 out-patients and 14,000 in-patients, as well as performing close to 4,000 operations.

Prof Zhang Guojun, Director of the Affiliated Cancer Hospital (second right), demonstrates the TrueBeam system to Mr. Li Ka-shing (first left), Mr. Hao Ping, Vice Minister of Education (second left), and Prof Gu Jiang, Dean of SUMC (first right).

Installation of the state-of-the-art radiotherapy system, TrueBeam, has been completed at the SUMC Affiliated Cancer Hospital and will soon be ready to treat its first cancer patients.

This article is based on content provided courtesy of the Li Ka Shing Foundation. For the full text of the original announcement, please see here.